Darjeeling Industries Q1FY27 net profit rises to ₹29.8 lakh
Darjeeling Industries posted a Q1FY27 standalone net profit of ₹29.78 lakh, up from a loss of ₹17.36 lakh in Q1FY25. Revenue rose to ₹145.87 lakh from ₹74.69 lakh in Q4FY26. Consolidated net profit stood at ₹25.29 lakh. The company received ₹50.00 lakh from convertible warrants during the quarter.

*this image is generated using AI for illustrative purposes only.
Darjeeling Industries Limited reported a return to profitability in the first quarter of FY27, posting a standalone net profit of ₹29.78 lakh for the period ended June 30, 2026. This marks a significant turnaround from the net loss of ₹17.36 lakh recorded in the same quarter of the previous fiscal year (Q1FY25).
Revenue from operations surged to ₹145.87 lakh, up from ₹74.69 lakh in the preceding quarter (Q4FY26). The company did not report revenue figures for Q1FY25, making year-on-year revenue comparisons unavailable. On a consolidated basis, which includes subsidiary Novva Defence Iinds Limited, the group reported a net profit of ₹25.29 lakh, compared to ₹7.09 lakh in Q4FY26.
Financial Performance
The improvement in profitability was underpinned by higher operational activity and favorable inventory movements. Key financial metrics for the quarter are outlined below:
| Metric: | Standalone Q1FY27 | Standalone Q4FY26 | Consolidated Q1FY27 |
|---|---|---|---|
| Revenue From Operations: | ₹145.87 lakh | ₹74.69 lakh | ₹145.87 lakh |
| Total Income: | ₹146.15 lakh | ₹76.14 lakh | ₹146.15 lakh |
| Total Expenses: | ₹106.45 lakh | ₹59.78 lakh | ₹112.45 lakh |
| Profit Before Tax: | ₹39.70 lakh | ₹16.35 lakh | ₹33.70 lakh |
| Net Profit After Tax: | ₹29.78 lakh | ₹7.09 lakh | ₹25.29 lakh |
| Basic EPS (₹): | 0.38 | 0.16 | 0.32 |
Other income contributed minimally at ₹0.28 lakh, down from ₹1.45 lakh in the previous quarter. Employee benefit expenses increased to ₹10.69 lakh from ₹4.41 lakh in Q4FY26, reflecting scaled-up operational efforts. Other expenses remained relatively stable at ₹6.99 lakh on a standalone basis.
What the Numbers Show
A notable divergence exists between the cash inflow from operations and the accounting recognition of expenses. While purchases of stock-in-trade amounted to ₹193.70 lakh, the company recorded a negative change in inventory of (₹104.93 lakh). This reduction in inventory levels effectively lowered the cost of goods sold, contributing significantly to the gross margin expansion that drove the return to profitability despite higher absolute purchase volumes compared to the prior quarter.
Capital Raise and Fund Utilization
The Board of Directors approved the receipt of ₹25.00 lakh towards convertible warrants allotted on September 23, 2025. The warrants were issued at a price of ₹16.80 each, including a premium of ₹6.80 per warrant, to non-promoter allottee Dilip Keshrimal Sanklecha.
The company filed a statement confirming no deviation or variation in the utilization of funds raised through the preferential issue of convertible warrants. The proceeds, originally allocated for working capital requirements (₹882.00 lakh) and general corporate purposes (₹294.00 lakh), are being utilized as per the approved objects. During the quarter ended June 30, 2026, an additional tranche of ₹50.00 lakh was received, bringing the cumulative utilization alignment with the stated objectives.
The unaudited financial results were reviewed by Sunit M Chhatbar & Co, Chartered Accountants, and approved by the Board in a meeting held on August 14, 2026.
Historical Stock Returns for Darjeeling Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.00% | +33.86% | -2.90% | -29.29% | -54.54% | +364.42% |
Can the profitability driven by inventory reduction be sustained in Q2FY27 as the company scales up operational activity and increases stock purchases?
How will the recent capital raise of ₹25.00 lakh via convertible warrants impact existing shareholder equity and future dilution risks?
What specific operational strategies is Darjeeling Industries implementing to maintain gross margin expansion amidst rising employee benefit expenses?


































